Influence of vaccination on adverse health outcomes after SARS-CoV-2 infection among individuals with alcohol use disorder: a population-based study.
Adverse outcomes
SARS-CoV-2 infection
alcohol use disorder
epidemiology
hospitalization
intensive care
mortality
population-based study
vaccination against SARS-CoV-2 infection
Journal
Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
08
08
2022
accepted:
28
02
2023
medline:
4
7
2023
pubmed:
4
4
2023
entrez:
3
4
2023
Statut:
ppublish
Résumé
Alcohol use disorders (AUD) have not been included in the priority groups for early vaccine against SARS-CoV-2. We aimed to determine adverse outcomes after SARS-CoV-2 infection among individuals with AUD and how this is modified by vaccination. This was a registry-based cohort study carried out in Denmark, 27 February 2020 to 15 October 2021, comprising 2157 individuals with AUD and 237 541 without AUD who had had a polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection during the study period. The association of AUD with the absolute and relative risk of hospitalization, intensive care and 60-day mortality after SARS-CoV-2 infection and of all-cause mortality throughout the follow-up period were measured. Potential interactions with SARS-CoV-2 vaccination, education and sex were explored in stratified analyses and tested by including interaction terms and using likelihood ratio tests. Individuals with AUD had an increased absolute and relative risk of adverse outcomes, including hospitalization [incidence rate ratio (IRR) = 1.72, 95% confidence interval (CI) = 1.51-1.95], intensive care (IRR = 1.47, 95% CI = 1.07-2.02) and 60-day mortality [mortality rate ratio (MRR) = 2.35, 95% CI = 1.94-2.85] compared with SARS-CoV-2-positive individuals without AUD. Irrespective of AUD, highest risks of these adverse health outcomes were observed for individuals not vaccinated against SARS-CoV-2 infection, for individuals of low educational level and in males. However, for all-cause mortality throughout the follow-up period, SARS-CoV-2 infection showed a lower relative mortality risk increase, whereas being unvaccinated showed a higher relative mortality risk increase, in individuals with AUD than in the reference population without AUD (P of interaction tests < 0.0001). Both alcohol use disorder and being unvaccinated for SARS-CoV-2 appear to be independent risk factors for adverse health outcomes following SARS-CoV-2 infection.
Sections du résumé
BACKGROUND AND AIMS
Alcohol use disorders (AUD) have not been included in the priority groups for early vaccine against SARS-CoV-2. We aimed to determine adverse outcomes after SARS-CoV-2 infection among individuals with AUD and how this is modified by vaccination.
DESIGN, SETTING AND PARTICIPANTS
This was a registry-based cohort study carried out in Denmark, 27 February 2020 to 15 October 2021, comprising 2157 individuals with AUD and 237 541 without AUD who had had a polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection during the study period.
MEASUREMENTS
The association of AUD with the absolute and relative risk of hospitalization, intensive care and 60-day mortality after SARS-CoV-2 infection and of all-cause mortality throughout the follow-up period were measured. Potential interactions with SARS-CoV-2 vaccination, education and sex were explored in stratified analyses and tested by including interaction terms and using likelihood ratio tests.
FINDINGS
Individuals with AUD had an increased absolute and relative risk of adverse outcomes, including hospitalization [incidence rate ratio (IRR) = 1.72, 95% confidence interval (CI) = 1.51-1.95], intensive care (IRR = 1.47, 95% CI = 1.07-2.02) and 60-day mortality [mortality rate ratio (MRR) = 2.35, 95% CI = 1.94-2.85] compared with SARS-CoV-2-positive individuals without AUD. Irrespective of AUD, highest risks of these adverse health outcomes were observed for individuals not vaccinated against SARS-CoV-2 infection, for individuals of low educational level and in males. However, for all-cause mortality throughout the follow-up period, SARS-CoV-2 infection showed a lower relative mortality risk increase, whereas being unvaccinated showed a higher relative mortality risk increase, in individuals with AUD than in the reference population without AUD (P of interaction tests < 0.0001).
CONCLUSIONS
Both alcohol use disorder and being unvaccinated for SARS-CoV-2 appear to be independent risk factors for adverse health outcomes following SARS-CoV-2 infection.
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1482-1492Informations de copyright
© 2023 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.
Références
World Health Organization. Strategy to achieve global Covid-19 vaccination by mid-2022 [Internet] [cited 2022 Jun 1]. Available from: https://cdn.who.int/media/docs/default-source/immunization/covid-19/strategy-to-achieve-global-covid-19-vaccination-by-mid-2022.pdf. Accessed 1 June 2022.
de Picker LJ, Dias MC, Benros ME, Vai B, Branchi I, Benedetti F, et al. Severe mental illness and European COVID-19 vaccination strategies. Lancet Psychiatry. 2021;8:356-359.
Danish Health Authority. The Danish Vaccination Programme Against COVID-19. Phases of the vaccination programme: main objectives of the vaccination programme [Internet] [cited 2022 Jun 1]. Available from: https://www.sst.dk/-/media/English/Publications/2021/Corona/Vaccination/The-Danish-Vaccination-Programme-Against-COVID-19.ashx?la=en&hash=C5AC701C8D17412ABA3B1871CF2BF2B90B1353E4. Accessed 1 June 2022.
Carvalho AF, Heilig M, Perez A, Probst C, Rehm J. Alcohol use disorders. Lancet. 2019;394:781-792.
Shield K, Manthey J, Rylett M, Probst C, Wettlaufer A, Parry CDH, et al. National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study. Lancet Public Health. 2020;5:e51-61.
Roerecke M, Rehm J. Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction. 2013;108:1562-1578. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23627868
Fond G, Nemani K, Etchecopar-Etchart D, Loundou A, Goff DC, Lee SW, et al. Association between mental health disorders and mortality among patients with COVID-19 in 7 countries: a systematic review and meta-analysis. JAMA Psychiatry. 2021;78:1208-1217.
Bhalla S, Sharma B, Smith D, Boley R, McCluskey C, Ilyas Y, et al. Investigating unhealthy alcohol use as an independent risk factor for increased COVID-19 disease severity: observational cross-sectional study. JMIR Public Health Surveill. 2021;7:e33022.
Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2021;26:30-39.
Yang H, Chen W, Hu Y, Chen Y, Zeng Y, Sun Y, et al. Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis. Lancet Healthy Longev. 2020;1:e69-79.
Nilsson SF, Laursen M, Osler M, Hjorthøj C, Benros ME, Ethelberg S. Adverse SARS-CoV-2-associated outcomes among people experiencing social marginalisation and psychiatric vulnerability: a population-based cohort study among 4,4 million people. Lancet Regional Health Europe. 2022;100421.
Nilsson SF, Laursen TM, Osler M, Hjorthøj C, Benros ME, Ethelberg S, et al. Vaccination against SARS-CoV-2 infection among vulnerable and marginalised population groups in Denmark: a nationwide population-based study. Lancet Regional Health Europe. 2022;16:100355.
Holst C, Tolstrup JS, Sørensen HJ, Becker U. Alcohol dependence and risk of somatic diseases and mortality: a cohort study in 19 002 men and women attending alcohol treatment. Addiction. 2017;112:1358-1366.
Katikireddi SV, Whitley E, Lewsey J, Gray L, Leyland AH. Socioeconomic status as an effect modifier of alcohol consumption and harm: analysis of linked cohort data. Lancet Public Health. 2017;2:e267-276.
Schmidt M, Pedersen L, Sørensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29:541-549.
Voldstedlund MAVM, Haarh M, Mølbak K, MiBa Board of Representatives. The Danish Microbiology Database (MiBa) 2010 to 2013. Euro Surveill. 2014;19:20667. [Internet]. Available from: www.eurosurveillance.org:pii=20667; http://www.eurosurveillance.org/ViewArticle.aspx?. Accessed 1 June 2022.
Schønning K, Dessau RB, Jensen TG, Thorsen NM, Wiuff C, Nielsen L, et al. Electronic reporting of diagnostic laboratory test results from all healthcare sectors is a cornerstone of national preparedness and control of COVID-19 in Denmark. APMIS. 2021;129:438-451.
Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449-490.
Pottegård A, Schmidt SAJ, Wallach-Kildemoes H, Sørensen HT, Hallas J, Schmidt M. Data resource profile: the Danish national prescription registry. Int J Epidemiol. 2017;46:798-798f.
Schwarz AS, Nielsen B, Nielsen AS. Changes in profile of patients seeking alcohol treatment and treatment outcomes following policy changes. J Public Health. 2018;26:59-67.
Askgaard G, Leon DA, Kjaer MS, Deleuran T, Gerds TA. Risk for alcoholic liver cirrhosis after an initial hospital contact with alcohol problems: a nationwide prospective cohort study. Hepatology. 2017;65:929-937.
Ahacic K, Damström-Thakker K, Kåreholt I. Recurring alcohol-related care between 1998 and 2007 among people treated for an alcohol-related disorder in 1997: a register study in Stockholm County. BMC Public Health. 2011;11:574. Available from: http://www.biomedcentral.com/1471-2458/11/574
Danish Health Authority. COVID-19 surveillance. 2022. Available from: https://sst.dk/en/English/Corona-eng/Status-of-the-epidemic/COVID-19-updates-Statistics-and-charts. Accessed 1 June 2022.
Chopra V, Flanders SA, O'Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021;174:576-578.
Siegfried S, Bopp M, Günthard H, Keiser O, Weibull CE, Crowther M, et al. Assessing relative COVID-19 mortality during the second wave: a prospective Swiss population-based study. BMJ Open. 2021;11:e051164.
Xu J, Yang X, Yang L, Zou X, Wang Y, Wu Y, et al. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China. Crit Care. 2020;24:394.
Blichert-Hansen L, Nielsson MS, Nielsen RB, Christiansen CF, Nørgaard M. Validity of the coding for intensive care admission, mechanical ventilation, and acute dialysis in the Danish national patient registry: a short report. Clin Epidemiol. 2013;5:9-12.
Grove Krause T, Jakobsen S, Haarh M, Mølbak K. The Danish vaccination register. Euro Surv. 2012;17:1. Available from: www.eurosurveillance.org; http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20155
Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39:91-94.
Momen NC, Plana-Ripoll O, Agerbo E, Benros ME, Børglum AD, Christensen MK, et al. Association between mental disorders and subsequent medical conditions. N Engl J Med. 2020;382:1721-1731.
Aalen O, Johansen S. An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Stat. 1978;5:141-150.
Rothman KJ, Greenland S, Lash T. Modern Epidemiology 3rd ed. Philadelphia, PA: Lippincott Williams & Williams; 2008. p. 128-147.
Reilev M, Kristensen KB, Pottegård A, Lund LC, Hallas J, Ernst MT, et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol. 2020;49:1468-1481.
Wang L, Wang QQ, Davis PB, Volkow ND, Xu R. Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021. World Psychiatry. 2022;21:124-132.
Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399:1303-1312.
Moghadas SM, Vilches TN, Zhang K, Wells CR, Shoukat A, Singer BH, et al. The impact of vaccination on coronavirus disease 2019 (COVID-19) outbreaks in the United States. Clin Infect Dis. 2021;73:2257-2264.
Hansen ABG, Hvidtfeldt UA, Grønbaek M, Becker U, Nielsen AS, Tolstrup JS. The number of persons with alcohol problems in the Danish population. Scand J Public Health. 2011;39:128-136.
Parimi K, Gilkeson K, Creamer BA. COVID-19 vaccine hesitancy: considerations for reluctance and improving vaccine uptake. Hum Vaccin Immunother. 2022;18:2062972.
Rehm J, Imtiaz S. A narrative review of alcohol consumption as a risk factor for global burden of disease. Subst Abuse Treat Prev Policy. 2016;11:37.
Barr T, Helms C, Grant K, Messaoudi I. Opposing effects of alcohol on the immune system overview of the immune system HHS public access. Prog Neuropsychopharmacol Biol Psychiatry. 2016;65:242-251.
Szabo G, Saha B. Alcohol's effect on host defense. Alcohol Res. 2015;37:159-170. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26695755%5Cn; http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4590613
Bellis MA, Hughes K, Nicholls J, Sheron N, Gilmore I, Jones L. The alcohol harm paradox: using a national survey to explore how alcohol may disproportionately impact health in deprived individuals. BMC Public Health. 2016;16:1-10.
Askgaard G, Leon DA, Deleuran T, Tolstrup JS. Hospital admissions and mortality in the 15 years after a first-time hospital contact with an alcohol problem: a prospective cohort study using the entire Danish population. Int J Epidemiol. 2019;16:1-9.
Rodrȷguez Artalejo F, de Andrés Manzano B, Guallar-Castillón P, Puente Mendizabal MT, González Enrȷquez J, del Rey Calero J. The Association of Tobacco and Alcohol Consumption with the use of health care services in Spain. Prev Med. 2000;31:554-561. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0091743500907345
Lasser KE, Kim TW, Alford DP, Cabral H, Saitz R, Samet JH. Is unhealthy substance use associated with failure to receive cancer screening and flu vaccination? A retrospective cross-sectional study. BMJ Open. 2011;1:e000046.